ArticleCancers2022

Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I-II Melanoma Patients at Risk of Disease Relapse.

Evalyn E A P Mulder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.